Victory Capital Management Inc. Buys 37,463 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Victory Capital Management Inc. raised its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 95.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 76,553 shares of the company’s stock after purchasing an additional 37,463 shares during the quarter. Victory Capital Management Inc. owned approximately 0.09% of Pediatrix Medical Group worth $1,004,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. Quest Partners LLC lifted its holdings in Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after purchasing an additional 622 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after acquiring an additional 1,040 shares in the last quarter. Quarry LP raised its holdings in Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after acquiring an additional 6,090 shares in the last quarter. Finally, FMR LLC raised its holdings in shares of Pediatrix Medical Group by 220.6% during the 3rd quarter. FMR LLC now owns 9,841 shares of the company’s stock worth $114,000 after buying an additional 6,771 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Trading Down 0.8 %

Shares of MD stock opened at $14.12 on Friday. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of -11.76, a PEG ratio of 1.74 and a beta of 1.49. The stock has a 50-day moving average of $14.28 and a 200-day moving average of $13.49. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently commented on MD. Macquarie began coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target for the company. UBS Group boosted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. Truist Financial boosted their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday, February 21st. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.